Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

B cells in Multiple Sclerosis: Good or bad guys?: An article for 28 May 2014 - World MS Day 2014.
ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
Protein 4.1R attenuates autoreactivity in experimental autoimmune encephalomyelitis by suppressing CD4(+) T cell activation.
Multiple Sclerosis and Antibodies against KIR4.1.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
Proteomics of a conundrum: thoughts on addressing the aetiology vs. progression of Multiple Sclerosis.
Interleukin-10 Gene-transfected Mature Dendritic Cells Suppress Murine Experimental Autoimmune Optic Neuritis.
"Response to the Commentary on "Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin"
Polyarteritis nodosa with central nervous system involvement mimicking relapsing-remitting multiple sclerosis.
Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation.
[MELATONIN TREATMENT OF AUTOIMMUNE AND ALLERGIC PATHOLOGY].
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Plasmocytoid dendritic cell deficit of early response to toll-like receptor 7 agonist stimulation in multiple sclerosis patients pDC deficit of early response to toll-like receptor 7 agonist stimulation.
Axonal Damage in Pediatric Multiple Sclerosis.
[Th17/Treg unbalance is involved in the pathogenesis of experimental autoimmune encephalomyelitis].
Neuromyelitis optica spectrum disorder presenting with repeated hypersomnia due to involvement of the hypothalamus and hypothalamus-amygdala linkage.
Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.
The Relationship Between Balance Confidence and Cognitive Motor Interference in Individuals With Multiple Sclerosis.
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis.
Multiple sclerosis: Regenerative therapies for MS-hope on the horizon.
Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
Disease mechanisms in MS: Cell adhesion molecule MCAM on pathogenic T cells-a green light for CNS entry in multiple sclerosis.

Pages